I agree that this site is using cookies. You can find further informations here.
X
Pace-Palitti, V.
47  results:
Search for persons X
?
1

Efficacy and safety of lusutrombopag in a real-world Italia..:

Gallo, P. ; De Vincentis, A. ; Pace-Palitti, V....
Digestive and Liver Disease.  56 (2024)  - p. S69-S70 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Real-world data on the treatment of primary biliary cholang..:

Vespasiani-Gentilucci, U. ; Pellicelli, A. ; Pace-Palitti, V....
Digestive and Liver Disease.  52 (2020)  - p. e33 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Symmetrical pitting edema resembling RS3PE in gout:

Palazzi, C. ; Olivieri, I. ; D'Amico, E...
Clinical Rheumatology.  22 (2003)  6 - p. 506-507 , 2003
Link: https://doi.org/10.1007/..
 
?
4

Non Insulin-Dependent Diabetes Mellitus (Type 2) Secondary ..:

Guagnano, M.T. ; Pace-Palitti, V. ; Manigrasso, M.R....
International Journal of Immunopathology and Pharmacology.  14 (2001)  1 - p. 31-43 , 2001
Link: https://doi.org/10.1177/..
 
?
5

OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE..:

Calvaruso, V. ; Celsa, C. ; Cristoferi, L....
Digestive and Liver Disease.  56 (2024)  - p. S153-S154 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Longer transplant-free and liver-related event-free surviva..:

Terracciani, F. ; De Vincentis, A. ; D'Amato, D....
Digestive and Liver Disease.  56 (2024)  - p. S3-S5 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Characterization of resistance profiles in HCV 2-3-4 DAA-na..:

Barbaliscia, S. ; Di Maio, V.C. ; Teti, E....
Digestive and Liver Disease.  50 (2018)  1 - p. 46-47 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Natural HCV resistance is common in Italy and differently a..:

Sorbo, M.C. ; Cento, V. ; Bertoli, A....
Digestive and Liver Disease.  49 (2017)  1 - p. e52 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Daclatasvir/sofosbuvir and ribavirin 800mg flat dose is hig..:

Pellicelli, A. ; Messina, V. ; Tarquini, P....
Digestive and Liver Disease.  49 (2017)  1 - p. e64 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Prevalence and characteristics of resistance associated sub..:

Di Maio, V.C. ; Barbaliscia, S. ; Lenci, I....
Digestive and Liver Disease.  49 (2017)  1 - p. e62-e63 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Impact of different Sofosbuvir-based direct acting antivira..:

Pellicelli, A.M. ; Pace Palitti, V. ; Vignally, P....
Digestive and Liver Disease.  48 (2016)  - p. e42 , 2016
Link: https://doi.org/10.1016/..
 
?
12

Prevalence and Characterization of Resistance Profiles of "..:

Khalili, O. El ; Chenwi, C. ; Di Maio, V.C....
Digestive and Liver Disease.  56 (2024)  - p. S35-S36 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Cholestasis impacts on performance of non invasive tests fo..:

Calvaruso, V. ; Celsa, C. ; Cristoferi, L....
Digestive and Liver Disease.  56 (2024)  - p. S28 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Long-term results from the Italian real-world experience on..:

Terracciani, F. ; De Vincentis, A. ; D'Amato, D....
Digestive and Liver Disease.  55 (2023)  - p. S44-S45 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Prediction of response to obeticholic acid in primary bilia..:

De Vincentis, A. ; Terracciani, F. ; D'Amato, D....
Digestive and Liver Disease.  55 (2023)  - p. S4-S5 , 2023
Link: https://doi.org/10.1016/..
 
1-15